TerrAscend (STU:TED) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:TED TerrAscend Corp STU:TED
46 GF Score
Price €0.52
GF Value €0.85
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is TerrAscend FFO per Share?

FFO per Share only applies to REITs.

STU:TED
46GF Score
TerrAscend Corp STU:TED
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TerrAscend (STU:TED) Overvalued in 2026?

Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued. The current stock price of €0.52 is trading 39.1% below its estimated GF Value™ of €0.85. GuruFocus considers TerrAscend to be Possible Value Trap.

Key valuation signals for STU:TED:

  • FFO per Share:
  • GF Value™: €0.85 vs. price of €0.52 (39.1% below fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the STU:TED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TerrAscend Business Description

Other Exchanges TSNDF:USATSND:Canada
Address 77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
46GF Score

Get the complete analysis for STU:TED

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.52
Price
€0.85
GF Value